Tagged with P

Singapore In an exclusive interview with Richard Saynor at GSK, he outlines the growth of the CEP portfolio in emerging markets and highlights the opportunities and challenges in the region, as well as the strategic benefits of operating in Singapore.   Even though our key medicines have many generic competitors, their…

Singapore Chin Yau Seng, President of Singapore Airlines Cargo, highlights how SIA Cargo supports Singapore’s reputation as a logistics hub in Asia Pacific and how the carrier has been able to adapt to the dynamic industry trends by tailoring their services to the customer’s needs. With twenty years of experience in…

Switzerland It is tempting to characterize Switzerland’s global pharma and life science hotspots as beginning and ending with Basel – home of industry giants Roche and Novartis. However, Zurich, Geneva, and even tiny Zug are all now staking serious claims for global recognition in this area. “Zurich is the world’s smallest…

Philippines Key executives and industry leaders convened in September in Manila to discuss the dynamic and evolving healthcare industry in the Philippines, and how QuintilesIMS’ expanding technological portfolio of services will best allow companies to drive their momentum in the future. Technology is also impacting other sectors in the country, including…

Singapore Paul Bruhn, Regional Business Head Asia, Oceania, MEA of Nestlé Health Science in Singapore, elaborates on the intricacies of these diverse regions and the strategic importance of Singapore as a hub for the region. You manage the AOA region out of Singapore, could you elaborate on what this region encompasses…

Mexico Mario Sturion, the recently appointed general manager of Janssen Mexico, assesses the specific challenges and opportunities of the Mexican health system and explains how a customized market access approach has been critical to Janssen’s success in a country noteworthy for the complexity of its public health system. You took over…

Philippines J. de Ruyter “Toto” C. Oroceo, President and General Manager of Delex Pharma International Inc. (DPII), and his team discuss the company’s rapid growth in the Philippines since 2013, the key areas driving success for the company as well as their plans to venture into manufacturing and expanding their business…

Philippines J. de Ruyter “Toto” C. Oroceo, President and General Manager of Delex Pharma International Inc. (DPII), and his team discuss the company’s rapid growth in the Philippines since 2013, the key areas driving success for the company as well as their plans to venture into manufacturing and expanding their business…

Switzerland Dr. Andrea Michael Meyer, general manager of Sanofi Genzyme Switzerland, reveals how the Swiss business has been experiencing year-on-year double-digit growth; how rare diseases was the foundation of Sanofi Genzyme´s business and remains a key part of their DNA; and how a focus on patient centricity remains at the core…

Singapore The founder and CEO of Vela Diagnostics, Michael Tillmann underscores the motivating drivers behind the establishment of the company and how their unique portfolio of automated PCR and NGS solutions have made clinical laboratory life easier for all companies across the molecular diagnostics value chain. He further highlights the crucial…

Singapore HGP Partner and Director of Asia, Ming Chua on the company’s reasons for using Singapore as the first point of entry into Asia, while highlighting the expansion of the country’s biomedical sciences sector as a major factor in HGP’s consistent year-on-year growth. He also speaks to the company’s qualities in…

Ireland Philip Martin, founder and CEO of Irish E-PPM software provider, Cora Systems, outlines his company’s successful growth in the past two decades, his bold plans for expansion into the US life sciences industry, and how his conviction in the strength of his product drives him every day. What was the…